Thu, July 14, 2016
Wed, July 13, 2016
Tue, July 12, 2016
Mon, July 11, 2016
Fri, July 8, 2016
Thu, July 7, 2016
Wed, July 6, 2016
Tue, July 5, 2016
Fri, July 1, 2016
Thu, June 30, 2016
Wed, June 29, 2016
Tue, June 28, 2016
Mon, June 27, 2016
Fri, June 24, 2016
Thu, June 23, 2016
Wed, June 22, 2016
Tue, June 21, 2016
Mon, June 20, 2016
Fri, June 17, 2016
Thu, June 16, 2016
Wed, June 15, 2016
Tue, June 14, 2016
Mon, June 13, 2016
Fri, June 10, 2016
Thu, June 9, 2016
Wed, June 8, 2016
Tue, June 7, 2016
Mon, June 6, 2016
Sun, June 5, 2016
Fri, June 3, 2016
Thu, June 2, 2016
Wed, June 1, 2016
Tue, May 31, 2016
Fri, May 27, 2016
Thu, May 26, 2016
Wed, May 25, 2016
Tue, May 24, 2016
Mon, May 23, 2016
Fri, May 20, 2016
Thu, May 19, 2016
Wed, May 18, 2016
Tue, May 17, 2016
Mon, May 16, 2016

Andrew Fein Downgraded (UTHR) to Hold and Decreased Target to $95 on, Jun 15th, 2016

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. and-decreased-target-to-95-on-jun-15th-2016.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Downgraded "United Therapeutics Corporation" (UTHR) to Hold and Decreased Target from $175 to $95 on, Jun 15th, 2016.

Andrew has made no other calls on UTHR in the last 4 months.



There are 3 other peers that have a rating on UTHR. Out of the 3 peers that are also analyzing UTHR, all agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jasper Hellweg of "Argus Research" Downgraded from Strong Buy to Hold on, Tuesday, May 24th, 2016
  • Matthew Kaplan of "Ladenburg Thalmann" Downgraded from Strong Buy to Hold on, Friday, April 29th, 2016
  • Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $145 on, Friday, February 26th, 2016